The global liquid biopsy market has witnessed a flurry of activity in the recent years, resulting in steady growth, at an impressive rate. This can be attributed to the increased patient preference for non-invasive tests and procedures, which has had a positive impact on the growth of liquid biopsy market. The study by Future Market Insights on the prospective expansion of the market estimates based on this, that the liquid biopsy market is likely to grow at approximately 21% globally, during the course of the forecast period.
There is a rising incidence and
subsequently the awareness of the increasing prevalence of cancer globally. The
testing of these cancers employs the use of liquid biopsy methods, to which the
growth and expansion of the global market can be attributed.
the Global Burden of Cancer Testing
The rising incidence of cancers and the
subsequent use of biopsies for testing has manufacturers focusing on reducing
the global economic burden of cancer testing. This has also caused an increase of
funding for the development of less invasive biopsy procedures that improve
patient outcomes and reduce recovery time, which has had a direct positive
impact on the growth of the global liquid biopsy market.
Biopsies versus Liquid Biopsies
Traditional tissue biopsies, which show the
molecular composition of tumour when the sample is taken, can be limited in
their results, as the heterogeneity is left undetected. The advantages offered
by a liquid biopsy include not just a full view of the probable malignancy’s
properties of the tumour, but also metastases and biochemical changes acquired
during blood-borne dissemination at a lower cost consuming less time.
Unlike a traditional surgical biopsy,
liquid biopsies are also minimally invasive procedures that offer the distinct
advantage to patients of reduced recovery time, among other benefits. These
factors have had significant impact on the evolution and growth of the liquid
biopsy market, as it continues to get popular globally, especially in developed
countries where penetration is the highest.
Manufacturers in the global liquid biopsy
market are increasingly looking to improve patient outcomes by focusing
research and development to improve the efficacy and the accuracy. However, due
to the slowdown from the financial crisis and the severe cut in the operational
funds across the market, the pace of innovation in the landscape has also
Markets within the Global Scenario
The global market for liquid biopsy is being propelled by rapid healthcare advancements and a shift towards value-based healthcare, which has spelled lucrative growth for manufacturers in the landscape. As the scenario currently stands, markets in developed regions have the most significant shares in the market, in a trend that is expected to continue to the end of the forecast period. This can be attributed to the rapid penetration into the landscape as they reap the first-mover advantage by being technologically advanced. However, the preference of conventional biopsies over liquid biopsy is expected to hamper the growth of the market in the developing regions
For more insights into the Market, request a sample of this report@https://www.futuremarketinsights.com/reports/sample/rep-gb-5593